We are monitoring the impact of COVID-19 on APAC Immunohistochemistry Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2740
Share on
Share on

Asia Pacific Immunohistochemistry Market Research Report – Segmented By Product, Application, End User & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts 2019-2024

Pulished: February, 2020
ID: 2740
Pages: 140

APAC Immunohistochemistry Market Size, Growth (2019 to 2024)

As per our research report, the size of the Asia Pacific Immunohistochemistry Market was valued at USD 490 million in 2019. It is estimated to be growing at a CAGR of 7.2%, to reach USD 690 million by 2024 during the forecast period.

The market is predicted to grow substantially in the mentioned forecast period as well as years to follow. Immunohistochemistry is a medical procedure used for the diagnosis of cancer. It involves the staining of a fresh or preserved cancer tissue that is removed from the patient’s body during the biopsy. This diagnostic process helps in the detection of hormone receptors on the surfaces of cancer cells. Immunohistochemistry is used for the diagnosis of cancers as well as tumour antibodies. It is an essential procedure for doctors as it helps them to know the tissue distribution of an antibody.

The Asia-Pacific Immunohistochemistry market is driven by factors like the ever-increasing population of the continent, an increasing number of cancer patients, and an emerging economy and increased the ability to spend on healthcare.

The primary constraints for this market are lack of awareness among the people about new technologies in the medical sector, unstable reimbursement scenario, and massive capital requirement.

This research report on Asia Pacific Immunohistochemistry Market has been segmented and sub-segmented into the following categories and evaluated market size and forecast for each segment until 2024.

  • By Product: Antibodies, Reagents, Equipment and Kits.
  • By Application: Diagnostics and Drug Testing.
  • By End User: Hospitals & Diagnostic Laboratories and Research Institutes.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

Regionally, the Asia-Pacific immunohistochemistry market is showcasing the fastest growth rate in the world. Economic development in the short period across this region is one of a primary factor leading growth. Also, the growing number of cancer patients and increasing expenditure on healthcare are further majorly enhancing market growth.

Chinese immunohistochemistry market is currently leading the Asia Pacific market, and the future is estimated to be more lucrative as per our research analysis. The government of China is coming up with well-organized and necessary precision medicine steps taken for increasing the demand towards the immunohistochemistry market growth of the APAC region.

On the other hand, Indian immunohistochemistry market is estimated to grow at a healthy rate during the forecast period due to increasing elder people population, the average increase of chronic and infectious diseases, and growing aging population are the factors boosting the immunohistochemistry growth.

Key Companies Operating the Asia Pacific Immunohistochemistry Market Profiled in the Report are F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Abcam plc, Cell Signaling Technology, Inc., and Bio SB Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Antibodies              

                                5.1.3 Reagents 

                                5.1.4 Equipment              

                                5.1.5 Kits             

                                5.1.6  Y-o-Y Growth Analysis, By Product              

                                5.1.7  Market Attractiveness Analysis, By Product            

                                5.1.8  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Diagnostics              

                                                5.2.2.1 Cancer

                                                5.2.2.2 Infectious Diseases

                                                5.2.2.3 Cardiovascular Diseases

                                                5.2.2.4 Autoimmune Diseases

                                                5.2.2.5 Diabetes Milletus

                                                5.2.2.6 Nephrological Diseases

                                5.2.3 Drug testing            

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application       

                                5.2.6 Market Share Analysis, By Application        

                5.3 End Users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals and Diagnostics Laboratories       

                                5.3.3 Research Institutes             

                                5.3.4 Y-o-Y Growth Analysis, By End Users           

                                5.3.5  Market Attractiveness Analysis, By End Users        

                                5.3.6  Market Share Analysis, By End Users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 F. Hoffman La Roche AG                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation                             

                8.3 Agilent Technologies                              

                8.4 Thermo Fischer Scientific Inc.                             

                8.5 Merck Millipore                        

                8.6 Bio-Rad Laboratories                              

                8.7 Cell Signalling Technology                     

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  2. Asia-Pacific Antibodies Market By Region, From 2019-2024 ( USD Million )
  3. Asia-Pacific Reagents Market By Region, From 2019-2024 ( USD Million )
  4. Asia-Pacific Equipment Market By Region, From 2019-2024 ( USD Million )
  5. Asia-Pacific Kits Market By Region, From 2019-2024 ( USD Million )
  6. Asia-Pacific Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  7. Asia-Pacific Diagnostics Market By Region, From 2019-2024 ( USD Million )
  8. Asia-Pacific Drug Testing Market By Region, From 2019-2024 ( USD Million )
  9. Asia-Pacific Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  10. Asia-Pacific Hospitals and Diagnostic Laboratories Market By Region, From 2019-2024 ( USD Million )
  11. Asia-Pacific Research Institutes Market By Region, From 2019-2024 ( USD Million )
  12. Japan Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  13. Japan Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  14. Japan Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  15. China Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  16. China Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  17. China Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  18. India Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  19. India Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  20. India Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  21. Australia Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  22. Australia Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  23. Australia Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  24. South Korea Immunohistochemistry Market By Product, From 2019-2024 ( USD Million )
  25. South Korea Immunohistochemistry Market By Application, From 2019-2024 ( USD Million )
  26. South Korea Immunohistochemistry Market By End User, From 2019-2024 ( USD Million )
  27. Asia-Pacific Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  28. Asia-Pacific Cancer Market By Region, From 2019-2024 ( USD Million )
  29. Asia-Pacific Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  30. Asia-Pacific Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  31. Asia-Pacific Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  32. Asia-Pacific Diabetes Mellitus Market By Region, From 2019-2024 ( USD Million )
  33. Asia-Pacific Nephrological Diseases Market By Region, From 2019-2024 ( USD Million )
  34. Japan Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  35. China Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  36. India Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  37. Australia Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  38. Asia-Pacific Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  39. Asia-Pacific Cancer Market By Region, From 2019-2024 ( USD Million )
  40. Asia-Pacific Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  41. Asia-Pacific Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  42. Asia-Pacific Autoimmune Diseases Market By Region, From 2019-2024 ( USD Million )
  43. Asia-Pacific Diabetes Mellitus Market By Region, From 2019-2024 ( USD Million )
  44. Asia-Pacific Nephrological Diseases Market By Region, From 2019-2024 ( USD Million )
  45. Japan Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  46. China Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  47. India Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )
  48. Australia Blood Glucose Monitoring Market By Diagnostics, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample